CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
56.06
22-November-24 15:44:58
15 minutes delayed
Stocks
-0.97
-1.70%
Today's range
55.34 - 57.10
ISIN
N/A
Source
NASDAQ
-
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
15 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
14 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
12 Nov 2024 15:07:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
12 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
11 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024
16 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
10 Oct 2024 15:40:28 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
08 Oct 2024 22:55:11 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
08 Oct 2024 15:01:51 By Nasdaq GlobeNewswire
-
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
26 Sep 2024 15:05:00 By Nasdaq GlobeNewswire
-
10 Sep 2024 15:40:25 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
29 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
12 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
08 Aug 2024 15:05:01 By Nasdaq GlobeNewswire
-
08 Aug 2024 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
18 Jul 2024 15:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jul 2024 18:29:44 By Nasdaq GlobeNewswire
-
18 Jun 2024 15:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jun 2024 17:35:30 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >